NMS · Analyst Forecast

Upstream Bio, Inc. (UPB) Stock Forecast & Price Target

$2.10 NMS: UPB Market Cap $115.10M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Upstream Bio, Inc. (UPB), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Upstream Bio, Inc., analysts forecast revenue rising from $2.68M in 2025 to $50.66M in 2030; the average estimate for 2030 earnings per share is −$2.93; with published estimates ranging from −$3.94 to −$1.66; 7 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$2.10
Consensus targetThe average of the price targets analysts have published.$25.00
Median targetThe middle target, less affected by a single outlier.$25.00
Highest targetThe most optimistic published target.$25.00
Lowest targetThe most pessimistic published target.$25.00
Difference from priceHow far the consensus target sits from today’s price.+1090.5%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$2.24M$2.68M$3.01M7
2026$1.61M$2.65M$3.00M7
2027$850,451$1.25M$1.65M6
2028$2.53M$3.79M$4.80M5
2029$6.15M$9.21M$11.66M2
2030$33.79M$50.66M$64.07M2

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$2.77−$2.60−$2.517
2026−$3.30−$2.87−$2.207
2027−$3.53−$2.83−$1.816
2028−$3.94−$2.93−$1.595
2029−$4.38−$3.26−$1.852
2030−$3.94−$2.93−$1.662

Upstream Bio, Inc. (UPB) forecast — frequently asked questions

What is the analyst price target for Upstream Bio, Inc.?

Analysts covering Upstream Bio, Inc. (UPB) have a consensus price target of $25.00, 1090.5% above the current price of $2.10. Published targets range from $25.00 to $25.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Upstream Bio, Inc.'s earnings?

The average analyst estimate for Upstream Bio, Inc. (UPB) earnings per share in 2030 is -2.93, with individual estimates between -3.94 and -1.66.

How much revenue is Upstream Bio, Inc. expected to make?

Analysts forecast Upstream Bio, Inc. (UPB) revenue of $50.66M in 2030, based on 2 published estimates.

How many analysts cover UPB?

7 analysts contribute estimates for Upstream Bio, Inc. (UPB). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.